ARTEGRAFT
Artegraft processes and sells biologic vascular grafts derived from bovine carotid arteries and implanted primarily in hemodialysis patients.
ARTEGRAFT
Industry:
Medical Device
Founded:
1993-01-01
Address:
North Brunswick, New Jersey, United States
Country:
United States
Website Url:
http://www.artegraft.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
SPF Amazon Microsoft Exchange Online Office 365 Mail GoDaddy DNS AWS Global Accelerator Vimeo GoDaddy Email
Official Site Inspections
http://www.artegraft.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Artegraft"
Artegraft - Crunchbase Company Profile & Funding
Jun 22, 2020 Organization. Artegraft . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. Artegraft offers surgeons a biological alternative to synthetic grafts. ... Artegraft is located in North โฆSee details»
Artegraft - Ownership and Business Overview - Mergr
Jun 22, 2020 Artegraftโs natural collagen matrix has proven long-term patency advantages over ePTFE and other synthetic graft materials. The company is also positioned as an alternative to โฆSee details»
Artegraft Company Profile 2024: Valuation, Investors ... - PitchBook
Artegraft General Information Description. Manufacturer of bovine carotid artery grafts based in North Brunswick, New Jersey. The company's grafts consist of a biological fibrous matrix โฆSee details»
Artegraft Company Profile - Office Locations, Competitors, โฆ
Artegraft is a company that provides surgeons with a biological alternative to synthetic grafts. It offers a collagen matrix that is intended for use distal to the aorta as a segmental arterial โฆSee details»
Artegraft, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Clinical Trials associated with Artegraft, Inc. NCT04146012 / Terminated Phase 3 Bovine Early Access, Compatibility and Hemostasis Post-Market Trial to Evaluate the Safety and โฆSee details»
Artegraft - Products, Competitors, Financials, Employees, โฆ
Artegraft processes and sells biologic vascular grafts that are derived from bovine carotid arteries and are implanted primarily in hemodialysis access patients. On June 22nd, 2020, Artegraft โฆSee details»
Artegraft - Overview, News & Competitors | ZoomInfo.com
View Artegraft org chart to access information on key employees and get valuable insights about Artegraft organizational structure. The organizational chart highlights the reporting lines within โฆSee details»
Artegraft Inc - Company Profile and News - Bloomberg Markets
Company profile page for Artegraft Inc including stock price, company news, executives, board members, and contact informationSee details»
Artegraft Inc - CAGE.report
Artegraft Inc. S.A.M. Registration: 6RZF5 [3683646] ARTEGRAFT INC : Company Details. Identification, Location & Contacts This profile was last updated: 04/01/2019 Status: ...See details»
Artegraft Inc - Company Details - medicalproductguide.com
Artegraft Inc 220 N Center Dr North Brunswick, NJ 08902 United States Phone:(732) 422-8333 Toll Free ... Email * First Name * Last Name * Organization Name * Profession * Professional โฆSee details»
LeMaitre Acquires Artegraft
LeMaitre Vascular, Inc. (Nasdaq: LMAT) has acquired the business and assets of Artegraft, Inc. for $90.0 million, including $72.5 million in cash paid at closing ($65.0 million to Artegraft plus โฆSee details»
LeMaitre Vascular acquires Artegraft - 2020-06-22 - Crunchbase
Jun 22, 2020 Artegraft Artegraft offers surgeons a biological alternative to synthetic grafts. Acquiring Organization: LeMaitre Vascular LeMaitre Vascular develops, manufactures, and โฆSee details»
Artegraft CEO and Key Executive Team | Craft.co
Artegraft's President and CEO is Richard Gibson. Other executives include Cathleen Vanderveer, Senior VP; Norris Horn, Senior VP & Chief Financial Officer and 3 others. See the full โฆSee details»
LeMaitre Vascular acquires Artegraft
Jul 2, 2020 Artegraft generated trade sales of US$15.6 million and estimated hospital-level sales of US$18.6 million during the twelve-month period ended 31 May 2020. Artegraftโs unit sales โฆSee details»
Artegraft - Qualifyze
Artegraft, Inc. is a producer of medical devices and equipment. This organization specializes in the fabrication and distribution of biological vascular grafts that originate from bovine carotid โฆSee details»
Artegraft Inc - HealthManagement.org
Artegraft, Inc. was incorporated in January, 1993, upon the divestiture of the bovine vascular graft business from Johnson & Johnson.Artegraft was the first vascular graft approved by the FDA โฆSee details»
Artegraft Revenue, Growth & Competitor Profile - IncFact.com
Nov 25, 2024 Trademark applications show the products and services that Artegraft is developing and marketing. Artegraft doesn't have any recent trademark applications, indicating โฆSee details»
Artegraft, Inc. - North Brunswick, New Jersey (NJ)
Artegraft is a natural collagen vascular graft. Its biological fibrous matrix is processed to enhance long term patency and provide a tightly woven, cross-linked conduit that is flexible & compliant. โฆSee details»
An Alternative Natural Vascular Access Graft - Transonic
Jan 16, 2019 A lesser know graft alternative is a bovine carotid artery graft (BCA) named Artegraft. 1 BCAโs biological material consists of a flexible tightly woven, cross-linked fibrous โฆSee details»
Artegraft® Collagen Vascular Graft - LeMaitre
The Journal of Vascular Access, Volume 15, No. 2, March-April 2014, Use of the Artegraft in Salvage of Arteriovenous Fistulas for Dialysis, Lesser DB. Journal of Vascular Surgery, โฆSee details»